261 related articles for article (PubMed ID: 33417512)
1. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.
Li G; Zhang C; Liang W; Zhang Y; Shen Y; Tian X
Pharm Biol; 2021 Dec; 59(1):21-30. PubMed ID: 33417512
[TBL] [Abstract][Full Text] [Related]
2. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
[TBL] [Abstract][Full Text] [Related]
3. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D
Idris S; Refaat B; Almaimani RA; Ahmed HG; Ahmad J; Alhadrami M; El-Readi MZ; Elzubier ME; Alaufi HAA; Al-Amin B; Alghamdi AA; Bahwerth F; Minshawi F; Kabrah SM; Aslam A
Life Sci; 2022 May; 296():120442. PubMed ID: 35245520
[TBL] [Abstract][Full Text] [Related]
5. Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer.
Le B; Powers GL; Tam YT; Schumacher N; Malinowski RL; Steinke L; Kwon G; Marker PC
PLoS One; 2017; 12(3):e0174658. PubMed ID: 28350865
[TBL] [Abstract][Full Text] [Related]
6. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.
Lv C; Zeng HW; Wang JX; Yuan X; Zhang C; Fang T; Yang PM; Wu T; Zhou YD; Nagle DG; Zhang WD
Cell Death Dis; 2018 Feb; 9(2):165. PubMed ID: 29416003
[TBL] [Abstract][Full Text] [Related]
7. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
8. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
9. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
Chen MH; Chiang KC; Cheng CT; Huang SC; Chen YY; Chen TW; Yeh TS; Jan YY; Wang HM; Weng JJ; Chang PM; Liu CY; Li CP; Chao Y; Chen MH; Huang CY; Yeh CN
Oncotarget; 2014 May; 5(9):2372-89. PubMed ID: 24796583
[TBL] [Abstract][Full Text] [Related]
10. L-securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 and influences the expression of genes involved in the PI3K/AKT/mTOR signaling pathway.
Han S; Zhang G; Li M; Chen D; Wang Y; Ye W; Ji Z
Oncol Rep; 2014 May; 31(5):2245-51. PubMed ID: 24676995
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling.
Yu L; Li F; Zhao G; Yang Y; Jin Z; Zhai M; Yu W; Zhao L; Chen W; Duan W; Yu S
Apoptosis; 2015 Jun; 20(6):796-810. PubMed ID: 25824534
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis.
van der Ploeg P; Uittenboogaard A; Thijs AMJ; Westgeest HM; Boere IA; Lambrechts S; van de Stolpe A; Bekkers RLM; Piek JMJ
Gynecol Oncol; 2021 Nov; 163(2):433-444. PubMed ID: 34253390
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.
Kim HJ; Gong MK; Yoon CY; Kang J; Yun M; Cho NH; Rha SY; Choi YD
Yonsei Med J; 2020 Jul; 61(7):587-596. PubMed ID: 32608202
[TBL] [Abstract][Full Text] [Related]
16. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
[TBL] [Abstract][Full Text] [Related]
17. Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis.
Dinesh P; Rasool M
Cytokine; 2018 Jun; 106():54-66. PubMed ID: 29549724
[TBL] [Abstract][Full Text] [Related]
18. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
19. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine.
Lee KH; Lo HL; Tang WC; Hsiao HH; Yang PM
Sci Rep; 2014 Sep; 4():6394. PubMed ID: 25227736
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.
Yi YW; Kang HJ; Kim HJ; Hwang JS; Wang A; Bae I
Mol Carcinog; 2013 Sep; 52(9):667-75. PubMed ID: 22488590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]